Tools for critical appraisal of evidence in studies of diagnostic accuracy

Autoimmunity Reviews

Volumn 12, Issue 2, 2012, Pages 89-96

  Giavarina, Davide ^a  

^a SAN BORTOLO HOSPITAL   (Italy)

Author keywords

Diagnostic test accuracy; Forest plot; Meta analysis; Sensitivity; Specificity; Summary ROC curve

Indexed keywords

AREA UNDER THE CURVE; CLINICAL EFFECTIVENESS; CONFIDENCE INTERVAL; DIAGNOSTIC ACCURACY; META ANALYSIS (TOPIC); PREDICTIVE VALUE; PROBABILITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECEIVER OPERATING CHARACTERISTIC; REVIEW; RISK; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW (TOPIC);

DIAGNOSTIC TESTS, ROUTINE; HUMANS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84870235199     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2012.07.004     Document Type: Review

References (39)

1. Evidence-Based Medicine Working Group Evidence-based medicine: a new approach to teaching the practice of medicine. JAMA 1992, 268:2420-2425.
2. Guyatt G. Evidence-based medicine. ACP J Club 1991, 114:A-16.
3. Cochrane A.L. Effectiveness and efficiency: random reflections on health services 1973, Nuffield Provincial Hospitals Trust, London.
4. Yerushalmy J. Statistical problems in assessing methods of medical diagnosis, with special reference to X-ray techniques. Public Health Rep 1947, 62:1432-1449.
5. Vecchio T.J. Predictive value of a single diagnostic test in unselected populations. N Engl J Med 1966, 274:1171-1173.
6. Galen R.S., Gambino S.R. Beyond normality: the predictive value and efficiency of medical diagnoses 1975, John Wiley, New York.
7. Henderson A.R., Bhayana V. A modest proposal for the consistent presentation of ROC plots in clinical chemistry. Clin Chem 1995, 41:1205-1206.
8. Albert A. On the use and computation of likelihood ratios in clinical chemistry. Clin Chem 1982, 28:1113-1119.
9. Jaeschke R., Guyatt G.H., Sackett D.L. Users' guides to the medical literature. VI. How to use an article about a diagnostic test. B: What are the results and will they help me in caring for my patients?. JAMA 1994, 271:703-707. for the Evidence-Based Medicine Working Group.
10. Fagan T.J. Nomogram for Bayes theorem. N Engl J Med 1975, 293:257.
11. Glas A.S., Lijmer J.G., Prins M.H., Bonsel G.J., Bossuyt P.M. The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol 2003, 56:1129-1135.
12. Statistics with confidence 2000, BMJ Books, Bristol. 2nd ed. D.G. Altman, D. Machin, T.N. Bryant, M.J. Gardner (Eds.).
13. Egger M., Smith G.D. Meta-analysis bias in location and selection of studies. BMJ 1998, 316:61-66.
14. [Last access January 17, 2012]. http://www.cochrane.org/resources/glossary.htm.
15. Lewis S., Clarke M. Forest plots: trying to see the wood and the trees. BMJ 2001, 322:1479-1480.
16. Mantel N., Haenszel W. Statistical aspects of the analysis of data from retrospectives studies of diseases. J Natl Cancer Inst 1959, 22:719-748.
17. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188.
18. Pereira R., Heneghan C. Systematic review and meta-analyses. Evidence-based laboratory medicine - principle, practice, and outcomes 2007, 245-274. AACC Press, Washington, DC. 2nd ed. C.P. Price, R.H. Christenson (Eds.).
19. Normand S.T. Tutorial in biostatistics. Meta-analysis: formulating, evaluating, combining, and reporting. Stat Med 1999, 18:321-359.
20. Deeks J.J., Altman D.G., Bradburn M.J. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. Systematic reviews in health care: meta-analysis in context 2001, 285-312. BMJ Books, London. 2nd ed. M. Egger, G. Davey Smith, D.G. Altman (Eds.).
21. Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. BMJ 2003, 327:557-560.
22. Higgins J.P.Y. Commentary: heterogeneity in meta-analysis should be expected and appropriately quantified. Int J Epidemiol 2008, 37:1158-1160.
23. Thompson S.G. Why sources of heterogeneity in meta-analysis should be investigated. BMJ 1994, 309:1351-1355.
24. Moses L.E., Shapiro D., Littenberg B. Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat Med 1993, 12:1293-1316.
25. Harbord R.M., Deeks J.J., Egger M., Whiting P., Sterne J.A. A unification of models for meta-analysis of diagnostic accuracy studies. Biostatistics 2007, 8:239-251. [Erratum in: Biostatistics 2008].
26. Walter S.D. Properties of the summary receiver operating characteristic (SROC) curve for diagnostic test data. Stat Med 2002, 21:1237-1256.
27. Boyd J.C. Statistical analysis and presentation of data. Evidence-based laboratory medicine - principle, practice, and outcomes 2007, 113-140. AACC Press, Washington, DC. 2nd ed. C.P. Price, R.H. Christenson (Eds.).
28. Price C.P., Glenn J.L., Christenson R.H. Applying evidence-based laboratory medicine. A step-by-step guide 2009, AACC Press, Washington, DC.
29. Dawes M., Summerskill W., Glasziou P., Cartabellotta A., Martin J., Hopayian K., et al. Second international conference of evidence-based health care teachers and developers. Statement on evidence-based practice. BMC Med Educ 2005, 5:1.
30. Guyatt G.H., Meade M.O., Jaeschke R.Z., Cook D.J., Haynes R.B. Practitioners of evidence based care. Not all clinicians need to appraise evidence from scratch but all need some skills. BMJ 2000, 320:954.
31. Heijstek M.W., Ott de Bruin L.M., Borrow R., van der Klis F., Koné-Paut I., Fasth A., et al. Vaccination in paediatric patients with auto-immune rheumatic diseases: a systemic literature review for the European League against Rheumatism evidence-based recommendations. Autoimmun Rev 2011, 11:112-122.
32. Zettl U.K., Stüve O., Patejdl R. Immune-mediated CNS diseases: a review on nosological classification and clinical features. Autoimmun Rev 2012, 11:167-173.
33. Petríková J., Lazúrová I. Ovarian failure and polycystic ovary syndrome. Autoimmun Rev 2012, 11:A471-A478.
34. Rutgers A., Kallenberg C.G. Refractory vasculitis. Autoimmun Rev 2011, 10:702-706.
35. Polido-Pereira J., Vieira-Sousa E., Fonseca J.E. Rheumatoid arthritis: what is refractory disease and how to manage it?. Autoimmun Rev 2011, 10:707-713.
36. Scoble T., Wijetilleka S., Khamashta M.A. Management of refractory anti-phospholipid syndrome. Autoimmun Rev 2011, 10:669-673.
37. Pietrogrande M., De Vita S., Zignego A.L., Pioltelli P., Sansonno D., Sollima S., et al. Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients. Autoimmun Rev 2011, 10:444-454.
38. van Assen S., Elkayam O., Agmon-Levin N., Cervera R., Doran M.F., Dougados M., et al. Vaccination in adult patients with auto-immune inflammatory rheumatic diseases: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for vaccination in adult patients with auto-immune inflammatory rheumatic diseases. Autoimmun Rev 2011, 10:341-352.
39. Selmi C., Tsuneyama K. Nutrition, geoepidemiology, and autoimmunity. Autoimmun Rev 2010, 9:A267-A270.